The Future of Global Vaccines - Market Forecasts to 2016, Stockpile Analysis, Competitive Benchmarking and Pipeline Analysis - GBI Research Reports

The Future of Global Vaccines - Market Forecasts to 2016, Stockpile Analysis, Competitive Benchmarking and Pipeline Analysis

The Future of Global Vaccines - Market Forecasts to 2016, Stockpile Analysis, Competitive Benchmarking and Pipeline Analysis - GBI Research Reports
The Future of Global Vaccines - Market Forecasts to 2016, Stockpile Analysis, Competitive Benchmarking and Pipeline Analysis
Published Dec 31, 2009
91 pages — Published Dec 31, 2009
Price US$ 3,500.00  |  Buy this Report Now

About This Report

  
Abstract:

SummaryGBI Research, the leading business intelligence provider, has released its latest research 'The Future of Global Vaccines - Market Forecasts to 2015, Stockpile Analysis, Competitive Benchmarking and Pipeline Analysis', which provides insights on the global vaccines sales, volume and price forecasts to 2015. The report provides in-depth analysis of unmet needs, drivers and barriers that impact the global vaccines market. The report analyzes the markets for vaccines in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Further, the report provides competitive benchmarking for the leading companies and also analyzes the mergers, acquisitions and licensing agreements that shape the global markets.This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.ScopeThe scope of this report includes:- Annualized market data for the global vaccines market from 2000 to 2008, forecast forward to 2015.- Analysis of the metabolic disorder therapeutics market in the leading geographies of the world. This includes the US, the UK, Germany, France, Italy, Spain, and Japan - Market characterization data on the global vaccines market including market size, market share and annual cost of vaccination. - Key drivers and restraints that have a significant impact on the market - Competitive landscape of the global vaccines market. The key companies studied in this report are Novartis AG, Sanofi Pasteur, Merck & Co, GlaxoSmithKline and Pfizer Inc.- Key M&A activities and licensing agreements that have taken place between 2008 and 2009 in the global vaccines market.Reasons to buyThe report will aid business development and marketing executives strategizing their product launches:- Build effective strategies to launch their pipeline products by identifying potential geographies. - Exploit in-licensing and out-licensing opportunities by identifying products that might fill their portfolio gaps. - Develop key strategic initiatives by studying the key strategies of top competitors. - Develop market-entry and market expansion strategies by identifying the geographic markets poised for strong growth. - Reinforce R&D pipelines by identifying new target mechanisms which can produce first in class vaccines with more efficiency and better safety.

  
Source:
Document ID
GBIHC025MR
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
By 2016, the Global Vaccines Market is Expected to Generate More Than Twice the Annual Revenue of 200911
The Vaccines Industry is Looking to Increase its Revenues Through the Introduction of Novel Vaccines and Indication Expansions for Established Products11
Licensing and Alliance Agreements Accounted for 81% of the M&A and Licensing Landscape21
1 Table of Contents35
List of Figures62
2 Introduction81
3 GBI Research Report Guidance91
4 The Future of Global Vaccines : Market Overview102
Vaccine Preventable Diseases101
4.2 Vaccine Manufacturing Process102
5 The Future of Global Vaccines: Global Vaccines Market1212
5.1 Market Forecasts121
5.1.1 Market Share by Disease Sectors131
5.1.2 Market Share by Geography141
5.2 Average Cost of Vaccination per Child141
5.3 Target Population152
5.3.1 Immunization Coverage172
5.4 Unmet Needs191
5.5 Market Trends201
5.5.1 Immunization Programs201
5.5.2 Public-Private Partnerships201
5.5.3 Production Capacity201
5.5.4 Reimbursements201
5.6 Drivers211
5.6.1 Growth will be Driven by Vaccines Targeting New Diseases 211
Adult Vaccines Segment will Provide Significant Boost to Growth of the Market211
5.6.3 Pediatric Combination Vaccines will Continue to Drive Growth221
5.6.4 Availability of Vaccine Technologies That Help Increase Efficacy and Safety will Drive Innovation and Growth221
5.6.5 Cancer and HIV/AIDS Vaccines Hold Significant Potential for the Future221
5.7 Barriers221
5.7.1 Limitations in Production Capacity Delays Realization of Potential221
5.7.2 High Initial Capital Investments and Technical Expertise Acts as Entry Barrier221
5.7.3 Lack of Harmonized Regulations Delays Vaccine Launch and Acceptance231
6 The Future of Global Vaccines: The US Vaccines Market246
Market Overview241
6.2 Market Forecasts241
6.3 Average Cost of Vaccination per Child251
6.4 Immunization Schedule261
6.5 Regulatory Framework262
6.6 Vaccine Procurement281
6.7 Vaccine Stockpiling282
7 The Future of Global Vaccines: European Vaccines Market3011
7.1 Market Overview301
7.2 Market Forecasts301
7.3 Average Cost of Vaccination per Child311
7.4 Vaccine Stockpiling321
7.5 The United Kingdom331
7.5.1 Immunization Schedule331
7.5.2 Regulatory Framework331
7.5.3 Vaccine Procurement331
7.6 France341
7.6.1 Immunization Schedule341
7.6.2 Regulatory Framework342
7.6.3 Vaccine Procurement361
7.7 Germany361
7.7.1 Immunization Schedule361
7.7.2 Regulatory Framework361
7.7.3 Vaccine Procurement371
7.8 Italy381
7.8.1 Immunization Schedule381
7.8.2 Regulatory Framework381
7.8.3 Vaccine Procurement391
7.9 Spain391
7.9.1 Immunization Schedule391
7.9.2 Regulatory Framework391
7.9.3 Vaccine Procurement401
8 The Future of Global Vaccines: Rest of the World413
8.1 Market Overview411
8.2 Market Forecasts411
8.3 Average Cost of Vaccination per Child411
8.4 Immunization Schedule421
8.5 Regulatory Framework421
8.6 Vaccine Procurement431
8.7 Vaccine Stockpiling431
9 The Future of Global Vaccines: Global Rotavirus Vaccines Market445
9.1 Market Overview441
9.2 Market Forecasts441
9.3 Average Cost of Vaccination451
9.4 Target Population461
9.4.1 Immunization Coverage461
9.5 Product Analysis471
9.5.1 RotaTeq471
9.5.1.1 Overview471
9.5.1.2 Indications471
9.5.1.3 Mechanism of action471
9.5.1.4 Dosage471
9.5.2 Rotarix471
9.5.2.1 Overview471
9.5.2.2 Indications481
9.5.2.3 Mechanism of action481
9.5.2.4 Dosage481
9.6 Vaccine Pipeline Analysis481
10 The Future of Global Vaccines: Global Pneumococcal Vaccines Market495
10.1 Market Overview491
10.2 Market Forecasts491
10.3 Average Cost of Vaccination501
10.4 Target Population511
10.4.1 Immunization Coverage511
10.5 Product Analysis521
10.5.1 Prevnar521
10.5.1.1 Overview521
10.5.1.2 Indications521
10.5.1.3 Mechanism of Action521
10.5.1.4 Dosage521
10.5.2 Synflorix531
10.5.2.1 Overview531
10.5.2.2 Indications531
10.5.2.3 Mechanism of action531
10.5.2.4 Dosage531
10.6 Vaccine Pipeline Analysis531
10.6.1.1 Prevnar 13 (Wyeth)531
11 The Future of Global Vaccines: Global Human Papillomavirus Vaccines Market546
11.1 Market Overview541
11.2 Market Forecasts541
11.3 Average Cost of Vaccination551
11.4 Target Population561
11.4.1 Immunization Coverage561
11.5 Product Analysis571
11.5.1 Gardasil571
11.5.1.1 Overview571
11.5.1.2 Indications571
11.5.1.3 Mechanism of Action571
11.5.1.4 Dosage571
11.5.2 Cervarix571
11.5.2.1 Overview571
11.5.2.2 Indications581
11.5.2.3 Mechanism of Action581
11.5.2.4 Dosage581
11.6 Vaccine Pipeline Analysis581
11.6.1 Profiles of Key Late Stage Vaccines581
11.6.1.1 V503 (Merck)581
11.6.1.2 HPV-16/18 L1/AS04 (GlaxoSmithKline)582
12 The Future of Global Vaccines: Global Seasonal Flu Vaccines Market608
12.1 Market Overview603
12.2 Market Forecasts631
12.3 Average Cost of Vaccination641
12.4 Target Population651
12.4.1 Immunization Coverage651
12.5 Product Analysis661
12.5.1 Fluzone661
12.5.1.1 Overview661
12.5.1.2 Indications661
12.5.1.3 Dosage661
12.5.2 Fluarix661
12.5.2.1 Overview661
12.5.2.2 Indications661
12.5.2.3 Dosage671
12.6 Vaccine Pipeline Analysis671
12.6.1 Profiles of Key Late Stage Vaccines671
12.6.1.1 Optaflu (Novartis)671
12.6.1.2 Intanza (Sanofi-Aventis)671
12.6.1.3 GSK2186877A671
13 The Future of Global Vaccines: Competitive Landscape689
13.1 Overview681
13.2 Market Share Analysis684
13.3 Competitor Profiles721
13.3.1 Sanofi Pasteur MSD721
13.3.2 Merck721
GlaxoSmithKline (GSK)731
13.3.4 Novartis741
13.3.5 Pfizer751
13.3.6 Sanofi Pasteur761
14 The Future of Global Vaccines : Strategic Consolidations7711
14.1 Mergers and Acquisitions772
14.1.1 Pfizer Acquires Wyeth for $68 billion791
14.1.2 BioSante Pharmaceuticals Acquires Cell Gensys791
14.1.3 Johnson &Johnson Acquires 18% Stake in Crucell791
14.2 Licensing Agreements793
14.2.1 Discovery Phase821
14.2.1.1 Scancell Ltd and ImmunoVaccine Technologies Inc.831
14.2.1.2 Regimmunue Corporation and Astellas Pharma Inc831
14.2.1.3 Protea Vaccine Technologies Ltd and GlaxoSmithKline Biologicals S.A831
14.2.2 Phase I831
14.2.2.1 ETEC Vaccine and Celldex Therapeutics, Inc831
14.2.2.2 Vical Incorporated and Naval Medical Research Center841
14.2.3 Phase II841
14.2.3.2 Novavax, Inc and Cadila Pharmaceuticals841
14.2.4 Phase III851
14.2.4.1 Immunotope Inc and ImmunoVaccine Technologies, Inc. (IVT)851
14.2.4.2 Nabi Biopharmaceuticals and GlaxoSmithKline (GSK)861
14.2.5 Filed for Approval and Approved861
14.2.5.1 Allergy Therapeutics and Nycomed Canada861
14.2.5.2 Csl Biotherapies and Merck &Co., Inc861
14.2.5.3 GlaxoSmithKline (GSK) and Fiocruz871
15 Appendix884
15.1 Market Definitions881
15.2 Key Support Data881
15.3 Abbreviations881
15.4 Methodology893
15.4.1 Coverage 901
15.4.2 Secondary Research901
15.4.3 Primary Research911
15.4.4 Expert Panel Validation911
15.5 Contact Us911
15.6 Disclaimer911

Table Of Contents

GBI Research Reports—GBI Research covers worldwide markets and issues, supplies actionable data and forecasts and is driven by industry leaders' insights. GBI Research provides a broad spectrum of reports across the healthcare and energy industries and its online offering is easy to navigate - a comprehensive resource for business information needs.

About the Author


Cite this Report

  
MLA:
GBI Research Reports. "The Future of Global Vaccines - Market Forecasts to 2016, Stockpile Analysis, Competitive Benchmarking and Pipeline Analysis" Dec 31, 2009. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GBI-Research-Reports/The-Future-of-Global-Vaccines-Market-Forecasts-to-2016-Stockpile-Analysis-Competitive-Benchmarking-and-Pipeline-Analysis-2115-16>
  
APA:
GBI Research Reports. (2009). The Future of Global Vaccines - Market Forecasts to 2016, Stockpile Analysis, Competitive Benchmarking and Pipeline Analysis Dec 31, 2009. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GBI-Research-Reports/The-Future-of-Global-Vaccines-Market-Forecasts-to-2016-Stockpile-Analysis-Competitive-Benchmarking-and-Pipeline-Analysis-2115-16>
  
US$ 3,500.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.